Our Constituencies

Diagnostics companies
Pharmaceutical companies
Medical device companies
Instrumentation companies
Technology companies
Start-up, investment stage, public and private companies
Companies working in emerging markets
Non-government organizations (NGOs)
Investment firms
Venture capital groups
Universities
Reference labs

Experience and Results

Halteres Introduction: Experience and Results

Testimonials

Mickey Urdea and Paul Neuwald head up the best diagnostic consulting outfit I know.
-Lance G. Laing, PhD, Executive Director, Business Development, ACEA Biosciences, Inc.

I would like to take this opportunity to thank the Halteres team. The project has so far provided a broader and often new perspective, which is very valuable.
–Steve Chen, PhD, Chief Operating Officer, Advanced Cell Diagnostics, Inc.

For a diagnostic startup company like ACD, the first product is of life or death importance, and you have only one chance to get it right. Halteres’ unique methodology and thorough process takes the guesswork out of selecting the optimum market opportunity thus maximizing the chances of success.
–Yuling Luo, PhD, President and CEO, Advanced Cell Diagnostics, Inc.

Halteres has consistently provided Angelica with the expertise we needed when we needed it. With depth and breadth – a one stop consultant shop.
–C. Geoff Davis, PhD, Angelica Therapeutics, Inc.

We were positively impressed by the productivity and depth of knowledge contributed by each of the Halteres team members. As renowned specialists with tremendous individual expertise in the IVD market and healthcare industry, they helped us to develop a sound business plan and to optimize Curetis' business strategy, on time and on budget. We thoroughly enjoyed working with them.
–Johannes Bacher & Andreas Boos, Managing Directors, Curetis AG

The team from Halteres has been helpful to me in every aspect of our business planning, from initial feasibility and market sizing, to product development, all the way through how we are going to get the product adopted and paid for.
–Daniel W. Paterson, President and CEO, DNAR, Inc.